-- Phase II SBIR funding to total approximately $1 Million dollars --

PITTSBURGH, PA - January 9, 2017 - RE2 Robotics, a leading developer of robotic manipulation systems, announced today that the company was awarded a Phase II Small Business Innovation Research (SBIR) grant from the US Army SBIR office and U.S. Army Telemedicine and Advanced Technology Research Center (TATRC) to develop robotic technologies to assist combat medics in the field.

The combat medic is one of the most dangerous and demanding responsibilities in warfare. Often in the course of reaching, assessing, and treating a wounded soldiers injuries, the combat medic and other personnel are placed directly in harms way. As a result many medics and soldiers have been injured or killed while trying to save others under hostile conditions. There is on-going interest to understand how unmanned systems can be used to reduce the risk of injury to the combat medic and other personnel when attempting to rescue and extract wounded soldiers in hostile or dangerous situations.
The objective of this program is to develop and demonstrate an innovative and novel medical module payload for future military ground vehicles that enable a single medic/ medical support person to evacuate a combat casualty. With this medical module payload one person is able to accomplish the extraction instead of the normal two which results in a force multiplier for the squad. RE2s medical module payload, called LIFELINE, will assist combat medics in maneuvering and evacuating wounded soldiers under extremely hostile conditions.
RE2 researched, designed and developed a LIFELINE prototype during Phase I of this SBIR program. The goal for Phase II will be to continue refining the design with major emphasis placed on weight reduction to reduce the burden on the soldier during installation. A final prototype will be developed to conclude the Phase II of this program.
"Our team is honored that the Army has selected RE2 once again to further develop technology to help improve the safety of our brave military personnel while in hazardous combat situations," stated Jorgen Pedersen, president and CEO of RE2. "The LIFELINE technology, in addition to our Patient Assist Robotic Arm and the ARIBO Assistive Arm programs, further extends our reach into the Healthcare market."
This work is supported by the US Army Medical Research and Materiel Command under Contract No. W8IXWH-16-C-0062. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

###
About RE2 Robotics
RE2 Robotics develops mobile robotic technologies that enable robot users to remotely interact with their world from a safe distance -- whether on the ground, in the air, or underwater. RE2 creates interoperable robotic manipulator arms with human-like performance, intuitive human robot interfaces, and advanced autonomy software for mobile robotics. For more information, please visit www.resquared.com or call 412.681.6382.